WILMINGTON, DE — A colorectal cancer screening program led by Privia Health (Nasdaq: PRVA) increased screening rates to 84 ...
Company Advances its Progress toward FDA Premarket Approval Study for its Next Generation Colorectal Cancer Screening Product and Makes a Strategic Acquisition in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results